More than 100,000 of us demanded Mylan drop the price of EpiPen. And on Thursday morning Mylan responded to consumer outrage with a claim that they’re makking EpiPen affordable for people who can’t afford it. But under the surface, the company didn’t actually change the price at all. The price cuts only apply to some underinsured consumers, who will get a $300 savings card. Everyone else, including anyone receiving Medicare or Medicaid, continues to pay the outrageous $600 price tag
Mylan has proven that it can not safely control the EpiPen patent. President Obama and the FDA have the authority to bust up the EpiPen monopoly. Add your name and demand that they do it.
Mylan’s announcement shows that Big Pharma is in full damage-control mode. They’re hoping to distract us from noticing that, although they’ve made EpiPen more accessible in the short term, they still haven’t lowered the actual list price. But more importantly, they’re hoping to take the heat off the monopoly system that allows companies like Mylan to make obscene profits off taxpayer-funded, life-saving drugs.
The industry is vulnerable, and if we don’t act now, we’re going to playing whack-a-mole with these drug corporations: every time we beat one price-gouge, another one will pop right up.
President Obama has the power to bust up Pharma monopolies on life saving medicines and the EpiPen is a great start. With the stroke of a pen, he can instruct the Food and Drug Administration (FDA) to strip Mylan of its EpiPen monopoly and open the door to busting up other monopolies on medicine.
The costs of lifesaving medicines have risen by double digits in recent years, and in many cases, including Epipen, significant taxpayer resources were involved in the original creation of the medications Big Pharma is now shamelessly profiteering from.
If we can get the FDA to strip Mylan’s monopoly over EpiPen, it will set an incredibly powerful precedent and finally put us on the road to making quality healthcare a human right, not a privilege.